SULLIVAN AMY (Chief Financial Officer) received a stock award from IO BIOTECH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/9/2023ACC: 0001140361-23-038879
Officer· Chief Financial Officer
Since Oct 2022
+98.76K
Net shares
Net buyer
$93.8K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
98.76K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+49.38K
Price / share
$1.90
Trade value
$93.83K
% of position
197.5%
8/9/2023
25K→74.38K
Total
Net shares
+49.38K
Net value
$93.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/9/2023 | A · Award | +49.38K | $1.90 | $93.83K | 197.5% | 25K | 74.38K |
| Total | +49.38K | $93.83K | ||||||
Derivative Transactions1
Warrants (Right to Buy)
Direct
Converts to
Common Stock
49.38K shares
Shares
+49.38K
Strike price
2.47
Held after
49.38K
Exercisable
—
8/9/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (Right to Buy) Direct | Common Stock49.38K shares | 8/9/2023 | A · Award | +49.38K | 2.47 | — | 49.38K |